Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva PharmafiledCriticalTeva Pharma
Publication of AR100262A1publicationCriticalpatent/AR100262A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Métodos de tratamiento de pacientes que sufren de la enfermedad de Crohn o de colitis ulcerosa que no experimentaron una respuesta clínica a la administración anterior de tiopurina, o que sufrieron efectos secundarios debidos a la administración anterior de tiopurina, que comprenden administrar una composición farmacéutica de liberación demorada que comprende 6-mercaptopurina. Se divulgan asimismo métodos de tratamiento de pacientes que sufren de la enfermedad de Crohn o de colitis ulcerosa, a quienes también se les administra un esteroide, ácido 5-aminsalicílico o un antibiótico, que comprenden administrar de manera conjunta una composición farmacéutica de liberación demorada que comprende 6-mercaptopurina.Methods of treatment of patients suffering from Crohn's disease or ulcerative colitis who did not experience a clinical response to the previous administration of thiopurine, or who suffered side effects due to the previous administration of thiopurine, comprising administering a pharmaceutical release composition delayed comprising 6-mercaptopurine. Methods of treatment of patients suffering from Crohn's disease or ulcerative colitis, who are also administered a steroid, 5-aminalicylic acid or an antibiotic, which together administer a delayed-release pharmaceutical composition, are also disclosed. It comprises 6-mercaptopurine.
ARP150101330A2014-05-022015-04-30
TREATMENT OF CROHN'S DISEASE WITH 6-DELAYED DELIVERY MERCAPTOPURINE
AR100262A1
(en)
INHIBITOR OF THE CHOLESTERILE ESTER TRANSFER PROTEIN (CETP) AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES